These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25782917)
1. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study. Shah SN; Manjunatha BS; Shah VS; Dagrus K; Soni N; Shah S Recent Pat Anticancer Drug Discov; 2015; 10(2):233-8. PubMed ID: 25782917 [TBL] [Abstract][Full Text] [Related]
2. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456 [TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis. Choudhari S; Masne S; Bhandare P; Dhumal S J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study. Gupta K; Metgud R; Gupta J J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537 [TBL] [Abstract][Full Text] [Related]
5. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma. Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma. Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941 [TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study. Sudha VM; Hemavathy S Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045 [TBL] [Abstract][Full Text] [Related]
8. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis. Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. Sutariya RV; Manjunatha BS J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of genotoxicity by micronucleus assay in the buccal mucosa over comet assay in peripheral blood in oral precancer and cancer patients. Katarkar A; Mukherjee S; Khan MH; Ray JG; Chaudhuri K Mutagenesis; 2014 Sep; 29(5):325-34. PubMed ID: 25053835 [TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study. Shraddha KS; Niranjan KC; Hallikeri K J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826 [TBL] [Abstract][Full Text] [Related]
12. Comparison of different stains in exfoliated oral mucosal cell micronucleus of potentially malignant disorders of oral cavity. Gupta J; Gupta K; Agarwal R J Cancer Res Ther; 2019; 15(3):615-619. PubMed ID: 31169229 [TBL] [Abstract][Full Text] [Related]
13. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study. Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271 [TBL] [Abstract][Full Text] [Related]
14. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review]. Kizhakkoottu S; Ramani P Arkh Patol; 2024; 86(1):57-64. PubMed ID: 38319274 [TBL] [Abstract][Full Text] [Related]
15. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study. Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review. Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571 [TBL] [Abstract][Full Text] [Related]
17. Mutation Analysis of the Dimer Forming Domain of the Caspase 8 Gene in Oral Submucous Fibrosis and Squamous Cell Carcinomas. Menon U; V P; Raghuram PH; Kannan K; Govindarajan GV; Ramanathan A Asian Pac J Cancer Prev; 2015; 16(11):4589-92. PubMed ID: 26107208 [TBL] [Abstract][Full Text] [Related]
18. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease. Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation. Angadi PV; Krishnapillai R Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409 [TBL] [Abstract][Full Text] [Related]
20. A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa. Sumedha S; Kotrashetti VS; Somannavar P; Nayak R; Babji D Biotech Histochem; 2015 May; 90(4):264-9. PubMed ID: 25539051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]